We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

USAC:NYSEUSA Compression Partners, LP Analysis

Data as of 2026-06-13 - not real-time

$26.73

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

USA Compression Partners posted a robust 35% year‑over‑year revenue increase to $1.08 billion and lifted Q1 EPS to $0.27, beating the Zacks consensus revenue estimate by 13% while marginally missing the EPS forecast. Operating margins remain healthy at 28.6% and free cash flow is solid at $255 million, supporting its generous 7.86% dividend yield. However, the dividend payout ratio sits above 200%, raising concerns about dividend sustainability given the company’s minimal cash balance ($14.5 million) and a staggering debt‑to‑equity ratio of 945. Technical indicators show a bullish SMA alignment (20‑day > 50‑day > 200‑day) but a bearish MACD and an RSI of 39, indicating the stock is near oversold conditions at $26.73, just above the $26.01 support level. The market’s “Extreme Greed” sentiment (fear‑greed index 89.86) and a modest upside of ~11% to the DCF‑derived fair value of $43 suggest room for price appreciation, yet the high 30‑day volatility (38%) and low beta (0.32) highlight a volatile but low‑beta profile. Overall, the stock presents a mixed picture: strong top‑line growth and cash generation counterbalanced by excessive leverage and an unsustainable dividend policy.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above key support at $26.01
  • High dividend yield but payout >200% suggests risk
  • Mixed technical signals (bullish SMA, bearish MACD, low RSI)

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 35% YoY and improving forward PE to 14.95
  • DCF fair value indicates ~11% upside and analyst median target $29.5
  • Strong operating cash flow and free cash flow generation

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Extremely high leverage (debt‑to‑equity 945) poses balance‑sheet risk
  • Energy equipment sector cyclicality and regulatory exposure
  • Unsustainable dividend policy may force future payout reductions

Key Metrics & Analysis

Financial Health

Revenue Growth35.10%
Profit Margin11.91%
P/E Ratio27.3
ROE84.75%
ROA6.65%
Debt/Equity945.48
P/B Ratio-30.1
Op. Cash Flow$425.7M
Free Cash Flow$255.5M
Industry P/E21.5

Technical Analysis

TrendBullish
RSI39.5
Support$26.01
Resistance$30.55
MA 20$28.58
MA 50$27.91
MA 200$25.57
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$43.32
Target Price$29.67
Upside/Downside10.99%
GradeFair
TypeGrowth
Dividend Yield7.86%

Risk Assessment

Beta0.32
Volatility38.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.